Bromocriptine in Treatment of Depression

Skirboll LR , Grace AA , Bunney BS . Dopamine auto and postsynaptic receptors. Electrophysiologic evidence for differential sensitivity to dopamine agonists. Science 1979; 206: 80–2.

Jimerson DC . Role of dopamine mechanisms in the affective disorders. In: Meltzer HY , ed. Psychopharmacology the third generation of progress. New York: Raven Press, 1987: 505–11.

Randrup A , Munkvad I , Fog R . Mania, depression, and brain dopamine. Curr Dev Psychopharmacol 1975; 2: 205–48.

Young JPR , Hughes WC , Lader M . A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Br Med J 1976; 1: 1116–8.

Berger PA , Faull KF , Kilkowski J . CSF monoamine metabolites in depression and schizophrenia. Am J Psychiatry 1980; 137: 174–80.

Koslow SH , Maas JW , Bowden CL , Davis JM , Hanin I , Javaid J . CSF and urinary biogenic amines and metabolites in depression and mania: a controlled univariate analysis. Arch Gen Psychiatry 1983; 40: 999–1010.

Aberg-Wistedt A , Wistedt B , Bertilsson L . Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression. Arch Gen Psychiatry 1985; 42: 925–6.

Jimerson DC , Cutler NR , Post RM . Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects. Psychiatr Res 1984; 13: 1–12.

Mendlewicz J , Van Cauter E , Linkowski P . The 24-hour profile of prolactin in depression. Life Sci 1980; 27: 2015–24.

Meltzer HY , Kolakowska T , Fang VS , Alagna SW , Loriaux DL . Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Arch Gen Psychiatry 1984; 41: 512–9.

Koppelman MCS , Parry BL , Hamilton JA , Alagna SW , Loriaux DL . Effect of bromocriptine on affect and libido in hyperprolactinemia. Am J Psychiatry 1987; 144: 1037–41.

Randrup A , Braestrup C . Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology 1977; 53: 309–14.

Golden RN , James SP , Sherer MA , Rudorfer MV , Sack DA , Potter WZ . Psychosis associated with bupropion treatment. Am J Psychiatry 1985; 142: 1459–62.

Serra G , Argiolas A , Klimek V , Fadda F , Gessa GL . Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci 1979; 25: 415–24.

Smialowski A , Maj J . Repeated treatment with imipramine potentiates the locomotor effect of apomorphine administered into the hippocampus in rats. Psychopharmacology 1985; 86: 468–71.

Agnoli A , Ruggieri S , Casacchia M . Restatement and perspectives of ergot alkaloids in clinical neurology and psychiatry. Pharmacology 1978; 16(suppl 1): 174–88.

Colonna L , Petit M , Lepine JP . Bromocriptine in affective disorders. J Affective Disord 1979; 1: 173–7.

Nordin C , Siwers B , Bertilsson L . Bromocriptine treatment of depressive disorders: clinical and biochemical effects. Acta Psychiatr Scand 1981; 64: 25–33.

Jouvent R , Abensour P , Bonnet AM , Widlocher D , Agid Y , Lhermitte F . Antiparkinson and antidepressant effects of high doses of bromocriptine: an independent comparison. J Affective Disord 1983; 5: 141–5.

Silverstone T . Response to bromocriptine distinguishes bipolar from unipolar depression. Lancet 1984; 1: 903–4.

Bouras N , Bridges PK . Bromocriptine in depression. Curr Med Res Opin 1982; 8: 150–3.

Waehrens J , Gerlach J . Bromocriptine and imipramine in endogenous depression: a double-blind controlled trial in outpatients. J Affective Disord 1981; 3: 193–202.

Theohar C , Fischer-Cornelssen K , Brosch H , Fischer EK , Petrovic D . A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression. Arzneimittelforschung 1982; 32: 783–7.